SECTION A5: CONTINUOUS LEARNING PIPELINE 
The self-improvement capability is the distinguishing feature of this project. The continuous 
learning pipeline must integrate three feedback sources: supervisor corrections, customer 
satisfaction scores, and resolution outcomes. 
A5.1 Supervisor Correction Loop 
Design must cover: sampling strategy (random, confidence-based, escalation-triggered, 
complaint-triggered); correction interface specification; correction taxonomy with severity levels 
(critical safety error, moderate quality issue, minor style improvement, false positive escalation); 
correction propagation timeline (immediate for safety issues, batched daily for quality, weekly 
for style); supervisor agreement metrics; and workload management (target: 50 reviews per 
supervisor per day). 
A5.2 Customer Satisfaction Signal 
Design must cover: in-conversation sentiment check at natural breakpoints; post-conversation 
CSAT rating (1-5) with optional free-text; implicit signals (resolution without escalation, return 
visits, time to resolution); dissatisfaction detection without explicit feedback; feedback bias 
correction; and feedback attribution to specific agent actions. 
A5.3 Resolution Outcome Tracking 
Design must cover: resolution verification follow-ups; repeat contact tracking (7/14/30 days); 
outcome classification (resolved-first-contact, resolved-with-escalation, unresolved-dropped, 
unresolved-escalated, false-resolution); and long-term outcome tracking connecting to customer 
retention and product adoption. 
A5.4 Safety Invariant Preservation 
The most critical aspect: fixed safety test suite (minimum 200 cases) that must pass before any 
model update; regression monitoring post-deployment; circuit breaker with automatic rollback; 
human-in-the-loop gate for safety-critical components; adversarial validation against red team 
tests; gradual rollout (1% > 5% > 25% > 100%); and an immutable rule-based safety layer that 
cannot be modified by the learning pipeline. 
 
 
Strictly Private and Confidential - Not for Circulation                                                                          Page number: 15 


## Page 16

 
 
 
 
